According to the Centers for Disease Control and Prevention (CDC), over 52 million adults in the U.S
To this end, we propose strategies such as advancing clinical trials and further exploring large animal models, which will help bridge the gap between preclinical findings and human therapeutic applications
Kim, K.-J., Baek, I.-W., Yoon, C.-H., Kim, W.-U
Ibrutinib induces durable remissions in treatment-nave CLL patients with 17p deletion/TP53 mutations: Five year follow-up from a phase 2 study
As a result, theyre ideal for shallow injections
While no mechanisms explaining those changes were suggested, additional studies have shown that neuroendocrine cells express CFTR [43]